|
|
Volumn 3 Suppl 1, Issue , 2002, Pages
|
|
Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
MONOCLONAL ANTIBODY;
PREDNISOLONE;
RITUXIMAB;
VAP CYCLO PROTOCOL;
VAP-CYCLO PROTOCOL;
VINCRISTINE;
ALLOTRANSPLANTATION;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
HUMAN;
METABOLISM;
MORTALITY;
NONHODGKIN LYMPHOMA;
PROGNOSIS;
RECURRENT DISEASE;
REVIEW;
STEM CELL TRANSPLANTATION;
TIME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CANCER VACCINES;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
LYMPHOMA, NON-HODGKIN;
PREDNISOLONE;
PROGNOSIS;
RECURRENCE;
STEM CELL TRANSPLANTATION;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
VINCRISTINE;
MLCS;
MLOWN;
|
|
EID: 0141889624
PISSN: 15269655
EISSN: None
Source Type: Journal
DOI: 10.3816/clm.2002.s.009 Document Type: Review |
|
Times cited : (10)
|
|
References (42)
|
